CDC is pulling back $11B in Covid funding sent to health departments across the U.S.

CDC is pulling back B in Covid funding sent to health departments across the U.S.


A general view of the Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Georgia.

Tami Chappell | Reuters

The Centers for Disease Control and Prevention is pulling back $11.4 billion in funds allocated in response to the pandemic to state and community health departments, nongovernment organizations and international recipients, the Department of Health and Human Services confirmed Tuesday.

“The COVID-19 pandemic is over, and HHS will no longer waste billions of taxpayer dollars responding to a non-existent pandemic that Americans moved on from years ago,” HHS Director of Communications Andrew Nixon said in a statement. “HHS is prioritizing funding projects that will deliver on President Trump’s mandate to address our chronic disease epidemic and Make America Healthy Again.

HHS oversees 13 agencies, including CDC, which is tasked with protecting the nation’s health. Notices began going out Monday and awardees have 30 days to reconcile their expenditures. Figures are subject to change.

The funding slash comes on the heels of other cuts under new Health and Human Services Secretary Robert F. Kennedy Jr., including the canceling of hundreds of millions of dollars in grants for research into vaccine hesitancy, LGBTQ populations and supporting HIV prevention.

“Now that the pandemic is over, the grants and cooperative agreements are no longer necessary as their limited purpose has run out,” read notices of termination sent to grantees on Monday and shared with NBC News.

The federal public health emergency ended May 11, 2023, but more than 1.2 million Americans have died from Covid according to the CDC. Though infection has slowed and the disease has become milder, hundreds of people still die every week from Covid, and long Covid symptoms continue to cause debilitating medical problems in some cases. 

The clawed-back funds were largely being used for Covid testing, vaccination, community health workers and initiatives to address Covid health disparities among high-risk and underserved populations, including racial and ethnic minority populations and rural communities, as well as global Covid projects, according to talking points emailed from CDC leadership to agency departments on Tuesday.

CDC reviewed a list of HHS-provided Covid grants and cooperative agreements and identified the programs that were no longer needed, according to the talking points.

A list of projects for the rescinded funds was not immediately available. Greg Flynn, media relations director for the Mississippi State Department of Health, confirmed the state had received notice of the funding decision and was “currently working to assess the potential impacts to our agency.”

Charla Haley, public information officer for Utah’s Department of Health, said in an email, “We are currently evaluating impact.”

So far, HHS has made the deepest budget cuts government-wide under the Trump administration’s efforts to radically slash federal funding, according to a tally listed on The Department of Government Efficiency’s website.

HHS also canceled $877 million in grants to the Texas Department of Health and $482 million to Florida’s health department among other cuts this week, according to DOGE’s website. 



Source

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to  billion
Health

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to $12 billion

A startup widely known as “ChatGPT for doctors” raised a new funding round that values the company at $12 billion. OpenEvidence, based in Miami, Florida, closed a $250 million financing, led by Thrive Capital and DST, the company told CNBC. The startup first raised outside capital in February, when it reeled in $75 million from […]

Read More
Another alliance of health care and AI signals why pharma stocks should be back in favor
Health

Another alliance of health care and AI signals why pharma stocks should be back in favor

Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with Microsoft’s AI-powered radiology platform to develop and launch imaging algorithms. These new tools, which can be used to […]

Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
Health

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US, on Friday, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0. Those are among the themes that dominated conversations last week as drugmakers […]

Read More